Degenerative spinal conditions are expected to propel the growth of the North American artificial disc replacement (ADR) market from $274.6m in 2016, to $614.5m by 2023, representing a compound annual growth rate (CAGR) of 12.2%, according to a report by GlobalData.
Titled ‘MediPoint: Artificial Disc Replacement – North America Analysis and Market Forecasts’, the report covers the Canada, Mexico and US markets.
The report identifies the key factors driving the growth of the degenerative spinal conditions industry among the ageing population. The advantages offered by ADR systems over traditional spinal fusion procedures such as motion preservation are helping to drive the growth.
Cervical disc replacement is the most common form of spinal non-fusion procedure across the globe. More recently, the increase in clinical efficacy and enhanced reimbursement scenarios have aided in the adoption of ADR systems, states GlobalData healthcare analyst Jennifer Ryan. Approval of cervical systems for use in multi-level indication is expected to drive growth in the global spinal non-fusion market.
Despite the impressive increase achieved by the cervical ADR system, lumbar ADR systems have not been able to achieve a similar growth due to lack of clinical efficacy evidence and the complications involved in the procedure, adds Ryan.
The global ADR market is dominated by large multinationals who have already established themselves in the orthopaedic and spine markets. Some of these include DePuy Synthes, Medtronic, Globus Medical, and Zimmer Biomet.
A number of small to mid-sized companies are also operating in the market. The report predicts an increase in mergers and acquisitions as the large multinationals aim to expand their product offerings.